Stocks · Real Estate · REIT - Healthcare Facilities
Diversified Healthcare Trust DHC
$7.54 -2.46% Close, Oct 5, 2026 · NASDAQ · Market cap $1.87B
Strong trendExpensive vs sector
Next earnings report: Nov 2, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -2.1% from 11.1% a year earlier.
- Net debt is 11.3× EBITDA, a high level of leverage.
- The stock is in an uptrend: above its 200-day average for 356 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Real Estate sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 22%
- FCF growth (TTM, YoY)Bottom 5%
- Revenue growth, 3-year CAGRTop 45%
- Revenue growth accelerationBottom 23%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 7%
- Gross marginBottom 10%
- Operating marginBottom 10%
- Accruals (lower is better)Top 20%
- Net debt / EBITDA (lower is better)Bottom 25%
- Interest coverBottom 11%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 9%
- Free-cash-flow yieldBottom 15%
- EBITDA / enterprise valueBottom 32%
- Sales / enterprise valueTop 12%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 2%
- 6-month returnTop 22%
- 1-year return vs S&P 500Top 1%
- Distance from 52-week highBottom 46%
- Trend checklist (0–4)Top 17%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 19%
- Consecutive EPS beatsBottom 18%
- Share of analysts rating BuyBottom 7%
- Upside to consensus price targetBottom 50%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 26%
- Maximum drawdown, 3 yearsBottom 27%
- Beta vs S&P 500 (lower is better)Top 2%
- Net debt / EBITDA (lower is better)Bottom 25%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 0.4% | -1.5% | ↓ |
| Gross margin | 17.8% | -5.2% | ↓ |
| Operating margin | 11.1% | -2.1% | ↓ |
| FCF margin | 5.9% | -6.4% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -1.5% | 0.4% | ↓ | Bottom 22% |
| Gross margin | -5.2% | 17.8% | ↓ | Bottom 10% |
| Operating margin | -2.1% | 11.1% | ↓ | Bottom 10% |
| Net margin | -17.7% | -18.8% | ↑ | — |
| Free-cash-flow margin | -6.4% | 5.9% | ↓ | — |
| Return on invested capital | -23.0% | — | Bottom 7% | |
| Revenue growth, 3-year CAGR | 6.2% | — | Top 45% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -98.5 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 11.32×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -0.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.52%
- Net buyback yield (TTM)
- 0.06%
- Shareholder yield
- 0.58%
- Share count change, 1 year
- +0.3%
- Share count change, 3-year CAGR
- +0.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 3, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +61.5%
- Average 2-day reaction, last 8
- +0.5%
- Positive 20 days after report
- 6 of 8
Analysts
- Consensus price target
- $9.25
- Target vs current price
- +22.7%
- Analysts with a rating
- 18
- Share rating Buy or Strong Buy
- 22%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 3, 2026 | -9.1% | -1.0% | -0.9% | -14.0% | — |
| May 4, 2026 | -14.9% | -1.0% | +7.8% | +4.7% | +13.4% |
| Feb 23, 2026 | +151.4% | -1.4% | +8.3% | +7.5% | +37.5% |
| Nov 3, 2025 | +118.6% | +3.8% | +4.9% | +13.4% | +37.8% |
| Aug 4, 2025 | +136.4% | +4.3% | +2.8% | +16.5% | +26.6% |
| May 5, 2025 | +124.0% | -4.0% | +33.0% | +39.2% | +44.9% |
| Feb 25, 2025 | -24.1% | +1.7% | +14.1% | +2.1% | +35.7% |
| Nov 4, 2024 | -57.7% | +1.4% | -24.2% | -22.8% | -28.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 3, 2026 | -$0.16 | -$0.15 | -9.1% | $365.4M |
| May 4, 2026 | -$0.18 | -$0.16 | -14.9% | $366.5M |
| Feb 23, 2026 | $0.09 | -$0.18 | +151.4% | $379.6M |
| Nov 3, 2025 | $0.04 | -$0.22 | +118.6% | $388.7M |
| Aug 4, 2025 | $0.08 | -$0.22 | +136.4% | $382.7M |
| May 5, 2025 | $0.06 | -$0.25 | +124.0% | $386.9M |
| Feb 25, 2025 | -$0.36 | -$0.29 | -24.1% | $379.6M |
| Nov 4, 2024 | -$0.41 | -$0.26 | -57.7% | $373.6M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / EBITDA | 20.5× | — | — | Bottom 32% |
| EV / Sales | 2.78× | — | — | Top 12% |
| Free-cash-flow yield | -5.16% | — | — | Bottom 15% |
| Earnings yield | -14.70% | — | — | Bottom 9% |
P/E over the past five years
Range 0.8× – 4.0× since Dec 31, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 356
- 50-day average slope (20 days)
- -6.1%
- 200-day average slope (20 days)
- +4.3%
- Distance from 50-day average
- -7.3%
- Distance from 200-day average
- +0.2%
- RSI (14)
- 34.3
- Relative volume
- 0.42×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 31.7%
- Volatility vs own 5-year history
- 0th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.00
- Correlation with S&P 500
- 0.00
- Current drawdown from 1-year high
- -21.8%
- Maximum drawdown, 3 years
- -51.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 15, 2021 | Dec 22, 2022 | -88.4% | 449 days | 762 days (Jan 8, 2026) |
| Nov 24, 2020 | Jan 4, 2021 | -23.2% | 26 days | 43 days (Mar 8, 2021) |
| Jul 21, 2026 | Sep 11, 2026 | -22.2% | 37 days | Not yet recovered |
| Oct 15, 2020 | Oct 30, 2020 | -21.6% | 11 days | 6 days (Nov 9, 2020) |
| Mar 4, 2026 | Mar 30, 2026 | -12.3% | 18 days | 20 days (Apr 28, 2026) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.87B
- EPS, diluted (TTM)
- -$1.11
- Revenue (TTM)
- $1.50B
- Dividend yield
- 0.53%
- 52-week range
- $3.92 – $9.66
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.38B | $1.28B | $1.41B | $1.50B | $1.54B |
| Gross profit | $291.4M | $174.5M | $225.3M | $256.4M | -$245.3M |
| Operating income | -$13.8M | -$91.2M | $199.2M | $229.9M | -$39.3M |
| Net income | $174.5M | -$15.8M | -$293.6M | -$370.3M | -$285.9M |
| EPS (diluted) | $0.73 | -$0.07 | -$1.23 | -$1.55 | -$1.19 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $373.6M | $379.6M | $386.9M | $382.7M | $388.7M | $379.6M | $366.5M | $365.4M |
| Net income | -$98.7M | -$87.4M | -$9.0M | -$91.6M | -$164.0M | -$21.2M | -$43.3M | -$37.4M |
| EPS (diluted) | -$0.41 | -$0.36 | -$0.04 | -$0.38 | -$0.68 | -$0.09 | -$0.18 | -$0.16 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$63.3M | -$40.4M | $10.5M | $112.2M | -$19.6M |
| Capital expenditure | $0 | $0 | $0 | $0 | $0 |
| Free cash flow | -$63.3M | -$40.4M | $10.5M | $112.2M | -$19.6M |
| Dividends paid | -$9.5M | -$9.6M | -$9.6M | -$9.6M | -$9.7M |
| Net share buybacks | -$383,000 | -$171,000 | -$393,000 | -$904,000 | -$1.1M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $116.8M
- Total assets
- $4.24B
- Total liabilities
- $2.66B
- Total debt
- $2.42B
- Net debt
- $2.30B
- Shareholders’ equity
- $1.58B
As of Jun 30, 2026 (filed Aug 3, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Jul 20, 2026 | $0.01 | Aug 13, 2026 |
| Apr 21, 2026 | $0.01 | May 14, 2026 |
| Jan 26, 2026 | $0.01 | Feb 19, 2026 |
| Oct 27, 2025 | $0.01 | Nov 13, 2025 |
| Jul 21, 2025 | $0.01 | Aug 14, 2025 |
| Apr 22, 2025 | $0.01 | May 15, 2025 |
| Jan 27, 2025 | $0.01 | Feb 20, 2025 |
| Oct 28, 2024 | $0.01 | Nov 14, 2024 |
Short interest
- Shares sold short
- 13,414,390
- Days to cover
- 8.40
- Change vs previous report
- +3.8%
FINRA short interest, settlement date Sep 15, 2026.